Editors' ChoiceCancer

TAMpering with TIME

See allHide authors and affiliations

Science Translational Medicine  04 Sep 2019:
Vol. 11, Issue 508, eaaz0308
DOI: 10.1126/scitranslmed.aaz0308

Abstract

CXCR2 inhibition reprograms tumor-associated macrophages to suppress prostate cancer progression.

View Full Text